Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel

Multiple endokrine Neoplasie 1

Die multiple endokrine Neoplasie 1 ist eine autosomal dominante Erkrankung, die durch Mutationen im MEN1-Gen ausgelöst wird.

Gliederung

Erbliche endokrinologische Erkrankungen
Autoimmune Polyendokrinopathie
Erbliche Erkrankungen der Hypophyse
Erkrankungen der Nebenschilddrüse
Genetische Erkrankungen der Nebenniere
Hereditärer Diabetes insipidus
Multiple endokrine Neoplasie 1
MEN1
Nierenerkrankungen mit endokrinologischer Manifestation
Störungen der Regulation des Wachstums
Störungen der Sexualentwicklung
Störungen des Schilddrüsenhormonsystems

Referenzen:

1.

Courseaux A et al. (1996) Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1).

[^]
2.

Rochelle JM et al. (1992) A linkage map of mouse chromosome 19: definition of comparative mapping relationships with human chromosomes 10 and 11 including the MEN1 locus.

[^]
3.

Simonds WF et al. (2004) Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome.

[^]
4.

Bear JC et al. (1985) Variant multiple endocrine neoplasia I (MEN IBurin): further studies and non-linkage to HLA.

[^]
5.

Farid NR et al. (1980) Prolactinomas in familial multiple endocrine neoplasia syndrome type I. Relationship to HLA and carcinoid tumors.

[^]
6.

Chandrasekharappa SC et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1.

[^]
7.

Agarwal SK et al. (1997) Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.

[^]
8.

Lemmens I et al. (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

[^]
9.

Darling TN et al. (1997) Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.

[^]
10.

Heppner C et al. (1997) Somatic mutation of the MEN1 gene in parathyroid tumours.

[^]
11.

Bassett JH et al. (1998) Characterization of mutations in patients with multiple endocrine neoplasia type 1.

[^]
12.

Guru SC et al. (1998) Menin, the product of the MEN1 gene, is a nuclear protein.

[^]
13.

Vortmeyer AO et al. (1998) Multiple endocrine neoplasia 1 gene alterations in MEN1-associated and sporadic lipomas.

[^]
14.

Prezant TR et al. (1998) Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors.

[^]
15.

Olufemi SE et al. (1998) Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland.

[^]
16.

Giraud S et al. (1998) Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.

[^]
17.

Teh BT et al. (1998) Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.

[^]
18.

Farnebo F et al. (1998) Alterations of the MEN1 gene in sporadic parathyroid tumors.

[^]
19.

Carling T et al. (1998) Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.

[^]
20.

Fujimori M et al. (1998) Novel V184E MEN1 germline mutation in a Japanese kindred with familial hyperparathyroidism.

[^]
21.

Heppner C et al. (1999) MEN1 gene analysis in sporadic adrenocortical neoplasms.

[^]
22.

Kjellman M et al. (1999) Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.

[^]
23.

Gisselsson D et al. (1999) Hibernomas are characterized by homozygous deletions in the multiple endocrine neoplasia type I region. Metaphase fluorescence in situ hybridization reveals complex rearrangements not detected by conventional cytogenetics.

[^]
24.

Cebrián A et al. (1999) Genetic and clinical analysis in 10 Spanish patients with multiple endocrine neoplasia type 1.

[^]
25.

Tahara H et al. (2000) Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia.

[^]
26.

Crabtree JS et al. (2001) A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

[^]
27.

Pannett AA et al. (2001) Somatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis.

[^]
28.

Guo SS et al. (2001) Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.

[^]
29.

Sato K et al. (2001) Somatic mutations of the MEN1 gene and microsatellite instability in a case of tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia.

[^]
30.

Turner JJ et al. (2002) Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1.

[^]
31.

Wautot V et al. (2002) Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.

[^]
32.

Okamoto H et al. (2002) A novel six-nucleotide insertion in exon 4 of the MEN1 gene, 878insCTGCAG, in three patients with familial insulinoma and primary hyperparathyroidism.

[^]
33.

Park JH et al. (2003) Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders.

[^]
34.

Ebeling T et al. (2004) Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations.

[^]
35.

Busygina V et al. (2004) Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1.

[^]
36.

Farnebo F et al. (1999) Alternative genetic pathways in parathyroid tumorigenesis.

[^]
37.

CUTLER RE et al. (1964) FAMILIAL HYPERPARATHYROIDISM. A KINDRED INVOLVING ELEVEN CASES, WITH A DISCUSSION OF PRIMARY CHIEF-CELL HYPERPLASIA.

[^]
38.

Warner J et al. (2004) Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications.

[^]
39.

Mallette LE et al. (1974) Parathyroid carcinoma in familial hyperparathyroidism.

[^]
40.

Tanaka C et al. (1998) Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.

[^]
41.

None (1976) Multiple endocrine adenomatosis syndromes.

[^]
42.

McCarthy DM et al. (1977) H2-Histamine receptor blocking agents in the Zollinger-Ellison syndrome. Experience in seven cases and implications for long-term therapy.

[^]
43.

Lamers CB et al. (1978) Prevalence of endocrine abnormalities in patients with the Zollinger-Ellison syndrome and in their families.

[^]
44.

Lamers CB et al. (1979) Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA I).

[^]
45.

Prosser PR et al. (1979) Prolactin-secreting pituitary adenomas in multiple endocrine adenomatosis, type I.

[^]
46.

Stadil F et al. (1976) Treatment of Zollinger-Ellison syndrome with streptozotocin.

[^]
47.

Straus E et al. (1977) Canine Zollinger-Ellison syndrome.

[^]
48.

Tateishi R et al. (1978) Coexistence of bilateral pheochromocytoma and pancreatic islet cell tumor: report of a case and review of the literature.

[^]
49.

Regan PT et al. (1978) A reappraisal of clinical, roentgenographic, and endoscopic features of the Zollinger-Ellison syndrome.

[^]
50.

Deveney CW et al. (1978) The Zollinger-Ellison syndrome--23 years later.

[^]
51.

Cocco AE et al. (1975) Zollinger-Ellison syndrome associated with ovarian mucinous cystadenocarcinoma.

[^]
52.

Larsson C et al. (1992) Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.

[^]
53.

Sawicki MP et al. (1992) Loss of heterozygosity on chromosome 11 in sporadic gastrinomas.

[^]
54.

Skogseid B et al. (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1.

[^]
55.

Richard CW et al. (1991) A radiation hybrid map of the proximal long arm of human chromosome 11 containing the multiple endocrine neoplasia type 1 (MEN-1) and bcl-1 disease loci.

[^]
56.

Fujimori M et al. (1992) Fine-scale mapping of the gene responsible for multiple endocrine neoplasia type 1 (MEN 1).

[^]
57.

Byström C et al. (1990) Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors.

[^]
58.

Nakamura Y et al. (1989) Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11.

[^]
59.

Bale SJ et al. (1989) Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11.

[^]
60.

Friedman E et al. (1989) Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1.

[^]
61.

Thakker RV et al. (1989) Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.

[^]
62.

Brandi ML et al. (1986) Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1.

[^]
63.

None (1986) Multiple endocrine neoplasia: search for the oncogenic trigger.

[^]
64.

Maton PN et al. (1986) Cushing's syndrome in patients with the Zollinger-Ellison syndrome.

[^]
65.

Bahn RS et al. (1986) Nonidentical expressions of multiple endocrine neoplasia, type I, in identical twins.

[^]
66.

Larsson C et al. (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

[^]
67.

Chedid A et al. (1988) Hereditary pituitary prolactinomas: a new rat model.

[^]
68.

Wolfe MM et al. (1987) Zollinger-Ellison syndrome. Current concepts in diagnosis and management.

[^]
69.

Guida PM et al. (1966) Zollinger-Ellison syndrome with interesting variations. Report of twelve cases including one of carcinoid of the duodenum.

[^]
70.

Jones BS et al. (1970) A case of the Zollinger-Ellison syndrome associated with hyperplasia of salivary and Brunner's glands.

[^]
71.

Friesen SR et al. (1972) Genetic aspects of the Z-E syndrome: prospective studies in two kindred; antral gastrin cell hyperplasia.

[^]
72.

Johnson GJ et al. (1967) Clinical and genetic investigation of a large kindred with multiple endocrine adenomatosis.

[^]
73.

Lulu DJ et al. (1968) Familial endocrine adenomatosis with associated Zollinger-Ellison syndrome. Wermer's syndrome.

[^]
74.

Way L et al. (1968) Zollinger-Ellison syndrome. An analysis of twenty-five cases.

[^]
75.

Vance JE et al. (1969) Nesidioblastosis in familial endocrine adenomatosis.

[^]
76.

Vance JE et al. (1972) Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis.

[^]
77.

Snyder N et al. (1972) Five families with multiple endocrine adenomatosis.

[^]
78.

Ellison EH et al. (1967) The Zollinger-Ellison syndrome updated.

[^]
79.

Buchta RM et al. (1971) Zollinger-Ellison syndrome in a nine-year-old child: a case report and review of the entity in childhood.

[^]
80.

Betts JB et al. (1980) Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1--report of a further family and a review of th literature.

[^]
81.

Reimer D et al. (1981) A kindred with 5 cases of multiple endocrine adenomatosis type I.

[^]
82.

Stacpoole PW et al. (1981) A familial glucagonoma syndrome: genetic, clinical and biochemical features.

[^]
83.

Mee AS et al. (1983) Changing concepts in the presentation, diagnosis and management of the Zollinger-Ellison syndrome.

[^]
84.

None (1984) Genetic aspects of multiple endocrine neoplasia.

[^]
85.

Hershon KS et al. (1983) Prolactinomas as part of the multiple endocrine neoplastic syndrome type 1.

[^]
86.

None (1982) Zollinger-Ellison syndrome.

[^]
87.

Long TT et al. (1980) Conservative management of the Zollinger-Ellison syndrome. Ectopic gastrin production by an ovarian cystadenoma.

[^]
88.

Petty EM et al. (1994) Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland.

[^]
89.

Gaitan D et al. (1993) Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type I.

[^]
90.

Guru SC et al. (1997) A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus.

[^]
91.

Lemmens I et al. (1997) Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

[^]
92.

None (1998) Multiple endocrine neoplasia--syndromes of the twentieth century.

[^]
93.

Sato M et al. (1998) Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families.

[^]
94.

Yu F et al. (1999) Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome.

[^]
95.

Guru SC et al. (1999) Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene.

[^]
96.

Hessman O et al. (2001) Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors.

[^]
97.

Schussheim DH et al. () Multiple endocrine neoplasia type 1: new clinical and basic findings.

[^]
98.

Bordi C et al. (2001) The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes.

[^]
99.

Brandi ML et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2.

[^]
100.

Vergès B et al. (2002) Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.

[^]
101.

None (1954) Genetic aspects of adenomatosis of endocrine glands.

[^]
102.

ZOLLINGER RM et al. (1955) Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas.

[^]
103.

WILLIAMS ED et al. (1962) The association of bronchial carcinoid and pluriglandular adenomatosis.

[^]
104.

UNDERWOOD LE et al. (1963) FAMILIAL ENDOCRINE ADENOMATOSIS. A FAMILY WITH HYPERINSULINISM AS THE PREDOMINANT MANIFESTATION.

[^]
105.

BALLARD HS et al. (1964) FAMILIAL MULTIPLE ENDOCRINE ADENOMA-PEPTIC ULCER COMPLEX.

[^]
106.

ELLISON EH et al. (1964) THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES.

[^]
107.

Hao W et al. (2004) Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma.

[^]
108.

Asgharian B et al. (2004) Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1.

[^]
109.

Scacheri PC et al. (2004) Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1.

[^]
110.

Perren A et al. (2007) Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas.

[^]
111.

Lemos MC et al. (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.

[^]
Update: 8. Juni 2020